Literature DB >> 34355689

Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021.

Brechje de Gier1, Stijn Andeweg1, Rosa Joosten1, Ronald Ter Schegget2, Naomi Smorenburg1, Jan van de Kassteele1, Susan Jm Hahné1, Susan van den Hof1, Hester E de Melker1, Mirjam J Knol1.   

Abstract

Several studies report high effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe disease, however an important knowledge gap is the vaccine effectiveness against transmission (VET). We present estimates of the VET to household and other close contacts in the Netherlands, from February to May 2021, using contact monitoring data. The secondary attack rate among household contacts was lower for fully vaccinated than unvaccinated index cases (11% vs 31%), with an adjusted VET of 71% (95% confidence interval: 63-77).

Entities:  

Keywords:  COVID-19; SARS-CoV-2; household study; transmission; vaccine effectiveness

Year:  2021        PMID： 34355689     DOI： 10.2807/1560-7917.ES.2021.26.31.2100640

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  21 in total

1.  Elevated risk of infection with SARS-CoV-2 Beta, Gamma, and Delta variant compared to Alpha variant in vaccinated individuals.

Authors:  Stijn P Andeweg; Harry Vennema; Mirjam J Knol; Dirk Eggink; Irene Veldhuijzen; Naomi Smorenburg; Dennis Schmitz; Florian Zwagemaker; Arianne B van Gageldonk-Lafeber; Susan J M Hahné; Chantal Reusken
Journal:  Sci Transl Med       Date:  2022-07-21       Impact factor: 19.319

Review 2.  Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants.

Authors:  Cong Sun; Chu Xie; Guo-Long Bu; Lan-Yi Zhong; Mu-Sheng Zeng
Journal:  Signal Transduct Target Ther       Date:  2022-06-28

3.  Networks of necessity: Simulating COVID-19 mitigation strategies for disabled people and their caregivers.

Authors:  Thomas E Valles; Hannah Shoenhard; Joseph Zinski; Sarah Trick; Mason A Porter; Michael R Lindstrom
Journal:  PLoS Comput Biol       Date:  2022-05-18       Impact factor: 4.779

4.  Transmission of SARS-CoV-2 within households: a remote prospective cohort study in European countries.

Authors:  Janneke D M Verberk; Marieke L A de Hoog; Ilse Westerhof; Sam van Goethem; Christine Lammens; Greet Ieven; Erwin de Bruin; Dirk Eggink; Julia A Bielicki; Samuel Coenen; Janko van Beek; Marc J M Bonten; Herman Goossens; Patricia C J L Bruijning-Verhagen
Journal:  Eur J Epidemiol       Date:  2022-05-28       Impact factor: 12.434

Review 5.  SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant.

Authors:  Eric A Meyerowitz; Aaron Richterman
Journal:  Infect Dis Clin North Am       Date:  2022-02-01       Impact factor: 5.905

6.  COVID-19 hospitalizations and deaths averted under an accelerated vaccination program in northeastern and southern regions of the USA.

Authors:  Thomas N Vilches; Pratha Sah; Seyed M Moghadas; Affan Shoukat; Meagan C Fitzpatrick; Peter J Hotez; Eric C Schneider; Alison P Galvani
Journal:  Lancet Reg Health Am       Date:  2021-12-29

7.  Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.

Authors:  Anika Singanayagam; Seran Hakki; Jake Dunning; Kieran J Madon; Michael A Crone; Aleksandra Koycheva; Nieves Derqui-Fernandez; Jack L Barnett; Michael G Whitfield; Robert Varro; Andre Charlett; Rhia Kundu; Joe Fenn; Jessica Cutajar; Valerie Quinn; Emily Conibear; Wendy Barclay; Paul S Freemont; Graham P Taylor; Shazaad Ahmad; Maria Zambon; Neil M Ferguson; Ajit Lalvani
Journal:  Lancet Infect Dis       Date:  2021-10-29       Impact factor: 25.071

Review 8.  Ethnic/racial minorities' and migrants' access to COVID-19 vaccines: A systematic review of barriers and facilitators.

Authors:  Mohammed Abba-Aji; David Stuckler; Sandro Galea; Martin McKee
Journal:  J Migr Health       Date:  2022-02-18

9.  Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge.

Authors:  Jennifer M Polinski; Andrew R Weckstein; Michael Batech; Carly Kabelac; Tripthi Kamath; Raymond Harvey; Sid Jain; Jeremy A Rassen; Najat Khan; Sebastian Schneeweiss
Journal:  JAMA Netw Open       Date:  2022-03-01

10.  Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis.

Authors:  Zachary J Madewell; Yang Yang; Ira M Longini; M Elizabeth Halloran; Natalie E Dean
Journal:  medRxiv       Date:  2022-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.